The development of medical technology in the last years of the 20th century has been very dynamic. Synthetic single-use products, artificial joint replacements, pacemaker technologies or minimal-invasive procedures result in a high standard of medical care. But despite of the huge progress in this field, we are presumably only at the beginning of a medical technology revolution.
The 1st version of the German Medizinproduktegesetz (MPG, Medical Devices Act) came into effect on January 1, 1995. It represents the national implementation of the European directives 90/385/EEC for active implantable medical device, 93/42/EEC for medical devices and 98/79/EEC for in vitro diagnostic devices.
With the implementation of this act in the EU internal market, the free movement of medical devices was established. Medical devices that are marketable in one member state of the EU are also marketable in the other EU countries. Manufacturers of medical devices can therefore place their products on the whole EU market.
The CE-mark on the products is the proof of complying with the essential requirements. The Medical Devices Act guarantees the efficacy and safety of the medical device because the product has to undergo comprehensive control procedures during the design and manufacturing process. The CE-mark is a cachet for quality and efficacy. After the market access, the authorities take care of the safety for users and consumers via definition of essential requirements.
This book presents the major aspects of the Medical Devices Act and the European directives. Moreover, the responsibilities and duties of a medical device manufacturer are explained as well as the product classifications and what the manufacturer has to keep in mind when designing and producing medical devices that comply with the legal requirements.
A lot of physicians implant medical devices without being aware of the highly complex registration landscape. Especially in clinical research, the regulations regarding the use of medical devices should be known. The requirements of the ethics committee and of the legal departments of hospitals are getting more complex and therefore especially the scientist should get acquainted with this topic.
Ph.D., biologist and chemist by education, has more than 18 years of experience in the field of medical devices as well as in the field of national and international medical device legislation - at Allergan Medical Optics (AMO) and Abbott Medical Optics. As “Manager Regulatory Affairs EMEA” at AMO she was responsible for several years for the registration process of all medical devices for AMO´s “Emerging Markets”. Moreover, she has been an active member in several working groups of EUCOMED, MECOMED and EUROMCONTACT, which contributed to her overall understanding and expertise in this field. Sibylle offers more than 22 years of experience in the ophthalmic medical device industry which resulted in high expertise and thorough understanding of developments, processes and future trends.
Myriam Becker
She has worked in the Medical Device industry for more than 15 years. For about 14 years she was responsible for Medical Device vigilance for Central and South Europe. From 2008 to 2012 she held the position of the deputy Medical Devices Safety Officer (Medizinproduktegesetz/Medical Devices Act § 30). In May 2012 Myriam moved to the Regulatory Affairs department at Abbott Medical Optics where she is responsible for “Regulatory Intelligence” and “review and approval of promotion and training materials” for the region Europe, Middle East and Africa. For more than 10 years she has been an Internal Auditor (Medical Devices); in December 2011 she additionally qualified as QMS Auditor/Lead Auditor (ISO13485:2003).
Stefan Menzl
Ph.D., serves as Director International Regulatory Affairs for Abbott Medical Optics (AMO). He is in charge of strategic planning, leadership and talent development for AMO´s International Regulatory Departments. Stefan currently manages all aspects of market access and product registration, regulatory compliance and relationship management with international regulatory governing bodies for AMO. In several regions he and his team are involved with obtaining reimbursement for AMO’s products. Stefan is a biologist by education and holds a Ph.D. in Microbiology and Biotechnology. He is an active member of the Regulatory Affairs Council of EUCOMED, a member of AdvaMed’s European Regulatory Working Group, the BVMed Working Group on Regulatory and Public Affairs (AKRP) and MECOMED’s Regulatory Working Group. He has been publishing numerous articles related to Regulatory matters.
Carsten Rupprath
Ph.D., is a chemist by education and holds a Ph.D. in Biotechnology. In 2007, Carsten started his career in the medical device industry as “Manager Regulatory Affairs Europe, Middle East, Africa” at Abbott Medical Optics (AMO) with the responsibility to register ophthalmological medical devices within the EMEA region. Since 2012, Carsten is in charge as “Director Regulatory Affairs” of a multinational team with the main tasks of product registration, market access and reimbursement of all AMO products within the EMEA region. He is an active member of the trade associations EUCOMED and EUROMCONTACT.
Es sind momentan noch keine Pressestimmen vorhanden.